Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery

BACKGROUND: The majority of patients with acute myelogenous leukemia (AML) still die of their disease. In order to improve survival rates in AML patients, new strategies are necessary to discover biomarkers for the detection and targeted therapy of AML. One of the advantages of the aptamer-based tec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mingli, Jiang, Guohua, Li, Wenjing, Qiu, Kai, Zhang, Min, Carter, Christopher M, Al-Quran, Samer Z, Li, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895837/
https://www.ncbi.nlm.nih.gov/pubmed/24405684
http://dx.doi.org/10.1186/1756-8722-7-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895837/
https://www.ncbi.nlm.nih.gov/pubmed/24405684
http://dx.doi.org/10.1186/1756-8722-7-5

Ejemplares similares